S
Senti Biosciences Inc
NASDAQ:SNTI
Senti Biosciences Inc
NASDAQ:SNTI
Price:
0.7901
USD
-10.36%
Market Closed
Market Cap:
$20.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Senti Biosciences Inc
NASDAQ:SNTI
|
US |
|
ATN International Inc
NASDAQ:ATNI
|
US |
|
Global Water Resources Inc
NASDAQ:GWRS
|
US |
|
G
|
Gungnir Resources Inc
OTC:ASWRF
|
CA |
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
CN |
|
Telefonaktiebolaget LM Ericsson
XETRA:ERCB
|
SE |
|
Bharat Electronics Ltd
NSE:BEL
|
IN |
|
B
|
Base Carbon Inc
NEO:BCBN
|
CA |
|
Americas Gold and Silver Corporation
TSX:USA
|
CA |
|
E
|
eBroker Group Ltd
HKEX:8036
|
HK |
|
Ssangyong Motor Co Ltd
KRX:003620
|
KR |
|
Trakm8 Holdings PLC
LSE:TRAK
|
UK |
|
Danone SA
OTC:GPDNF
|
FR |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
|
Wah Lee Industrial Corp
TWSE:3010
|
TW |
|
E
|
Estrella Immunopharma Inc
NASDAQ:ESLA
|
US |
Income Statement
Earnings Waterfall
Senti Biosciences Inc
Senti Biosciences Inc
Income Statement
Senti Biosciences Inc
Senti Biosciences Inc
Currency: USD
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
2
N/A
|
3
+40%
|
4
+37%
|
4
+15%
|
5
+15%
|
4
-15%
|
4
+4%
|
4
-9%
|
3
-35%
|
3
-2%
|
1
-50%
|
0
-73%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(38)
|
(43)
|
(47)
|
(60)
|
(64)
|
(66)
|
(71)
|
(66)
|
(68)
|
(69)
|
(95)
|
(93)
|
(63)
|
(61)
|
(61)
|
(65)
|
(66)
|
|
| Selling, General & Administrative |
(19)
|
(21)
|
(22)
|
(32)
|
(34)
|
(38)
|
(43)
|
(38)
|
(38)
|
(37)
|
(35)
|
(29)
|
(25)
|
(24)
|
(23)
|
(26)
|
(26)
|
|
| Research & Development |
(19)
|
(22)
|
(25)
|
(29)
|
(30)
|
(28)
|
(30)
|
(27)
|
(30)
|
(32)
|
(34)
|
(36)
|
(36)
|
(34)
|
(35)
|
(36)
|
(38)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(26)
|
(26)
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(36)
N/A
|
(40)
-12%
|
(43)
-7%
|
(56)
-30%
|
(59)
-6%
|
(62)
-5%
|
(67)
-8%
|
(62)
+8%
|
(65)
-6%
|
(67)
-3%
|
(94)
-41%
|
(92)
+2%
|
(63)
+32%
|
(61)
+4%
|
(61)
-1%
|
(65)
-6%
|
(66)
-3%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
3
|
2
|
2
|
1
|
14
|
14
|
14
|
14
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
(26)
|
(26)
|
0
|
0
|
(1)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(9)
|
(15)
|
(3)
|
9
|
9
|
9
|
10
|
1
|
8
|
6
|
10
|
12
|
(8)
|
(6)
|
(8)
|
(8)
|
4
|
|
| Pre-Tax Income |
(45)
N/A
|
(55)
-22%
|
(46)
+17%
|
(46)
+1%
|
(49)
-6%
|
(50)
-2%
|
(55)
-10%
|
(57)
-5%
|
(80)
-39%
|
(83)
-5%
|
(82)
+2%
|
(79)
+4%
|
(71)
+10%
|
(53)
+26%
|
(55)
-4%
|
(58)
-6%
|
(48)
+18%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(45)
|
(55)
|
(46)
|
(46)
|
(49)
|
(50)
|
(55)
|
(57)
|
(80)
|
(83)
|
(82)
|
(79)
|
(71)
|
(53)
|
(55)
|
(58)
|
(48)
|
|
| Net Income (Common) |
(45)
N/A
|
(55)
-22%
|
(46)
+17%
|
(46)
+1%
|
(51)
-11%
|
(58)
-14%
|
(65)
-12%
|
(72)
-11%
|
(71)
+2%
|
(71)
-1%
|
(64)
+9%
|
(57)
+12%
|
(71)
-24%
|
(53)
+26%
|
(55)
-4%
|
(58)
-6%
|
(48)
+18%
|
|
| EPS (Diluted) |
-10.42
N/A
|
-12.67
-22%
|
-10.56
+17%
|
-10.53
+0%
|
-11.72
-11%
|
-13.21
-13%
|
-14.77
-12%
|
-16.32
-10%
|
-15.86
+3%
|
-16.01
-1%
|
-14.09
+12%
|
-12.45
+12%
|
-15.48
-24%
|
-11.49
+26%
|
-5.47
+52%
|
-2.23
+59%
|
-1.81
+19%
|
|
Switch to:
Switch to:
See Also
Discover More
